Nirman Agri Genetics Limited (NSE:NIRMAN)
India · Delayed Price · Currency is INR 53.15
+2.50 (4.94%)
At close: Jan 23, 2026
Nirman Agri Genetics Revenue
Nirman Agri Genetics had revenue of 731.14M INR in the quarter ending September 30, 2025, with 17.75% growth. This brings the company's revenue in the last twelve months to 2.70B, up 78.07% year-over-year. In the fiscal year ending March 31, 2025, Nirman Agri Genetics had annual revenue of 2.37B with 273.43% growth.
Revenue (ttm)
2.70B
Revenue Growth
+78.07%
P/S Ratio
0.16
Revenue / Employee
71.13M
Employees
38
Market Cap
425.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.37B | 1.73B | 273.43% |
| Mar 31, 2024 | 633.37M | 347.29M | 121.40% |
| Mar 31, 2023 | 286.08M | 151.19M | 112.08% |
| Mar 31, 2022 | 134.89M | 69.37M | 105.87% |
| Mar 31, 2021 | 65.52M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sheel Biotech | 1.12B |
| Vishwas Agri Seeds | 1.02B |
| Saptarishi Agro Industries | 1.00B |
| Unisem Agritech | 690.78M |
| Continental Seeds and Chemicals | 677.88M |
| Stanbik Agro | 524.85M |
| Nagarjuna Agri-Tech | 202.80M |
| Shree Ganesh Bio-Tech (India) | 195.69M |